Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISTA: Vitamin K1 for INR Stability in Hemodialysis
NCT02324686Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jan 2014
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label trial of phytomenadione in Atrial fibrillation (AFib), sponsored by University Health Network. Primary endpoint: Standard deviation of INR values at 4 months. Started Jan 2014; status: completed.
02
Drugs
phytomenadione
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02324686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02324686.